330 related articles for article (PubMed ID: 23333498)
1. Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation.
Chen H; Landen CN; Li Y; Alvarez RD; Tollefsbol TO
Exp Cell Res; 2013 Mar; 319(5):697-706. PubMed ID: 23333498
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and Sulforaphane.
Chen H; Landen CN; Li Y; Alvarez RD; Tollefsbol TO
J Oncol; 2013; 2013():872957. PubMed ID: 23476648
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells.
Bryant CS; Kumar S; Chamala S; Shah J; Pal J; Haider M; Seward S; Qazi AM; Morris R; Semaan A; Shammas MA; Steffes C; Potti RB; Prasad M; Weaver DW; Batchu RB
Mol Cancer; 2010 Mar; 9():47. PubMed ID: 20196847
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines.
Meeran SM; Patel SN; Tollefsbol TO
PLoS One; 2010 Jul; 5(7):e11457. PubMed ID: 20625516
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells.
Nair S; Hebbar V; Shen G; Gopalakrishnan A; Khor TO; Yu S; Xu C; Kong AN
Pharm Res; 2008 Feb; 25(2):387-99. PubMed ID: 17657594
[TBL] [Abstract][Full Text] [Related]
6. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
Huh SW; Bae SM; Kim YW; Lee JM; Namkoong SE; Lee IP; Kim SH; Kim CK; Ahn WS
Gynecol Oncol; 2004 Sep; 94(3):760-8. PubMed ID: 15350370
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
[TBL] [Abstract][Full Text] [Related]
8. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK
Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation.
Martin SL; Kala R; Tollefsbol TO
Curr Cancer Drug Targets; 2018; 18(1):97-106. PubMed ID: 28176652
[TBL] [Abstract][Full Text] [Related]
10. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention.
Wang L; Liu D; Ahmed T; Chung FL; Conaway C; Chiao JW
Int J Oncol; 2004 Jan; 24(1):187-92. PubMed ID: 14654956
[TBL] [Abstract][Full Text] [Related]
11. Optimizing combination therapy in prostate cancer: mechanistic insights into the synergistic effects of Paclitaxel and Sulforaphane-induced apoptosis.
Habib TN; Altonsy MO; Ghanem SA; Salama MS; Hosny MA
BMC Mol Cell Biol; 2024 Mar; 25(1):5. PubMed ID: 38438917
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase.
Moradzadeh M; Hosseini A; Erfanian S; Rezaei H
Pharmacol Rep; 2017 Oct; 69(5):924-928. PubMed ID: 28646740
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells.
Nair S; Barve A; Khor TO; Shen GX; Lin W; Chan JY; Cai L; Kong AN
Acta Pharmacol Sin; 2010 Sep; 31(9):1223-40. PubMed ID: 20729872
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effects of the major tea polyphenol, (-)-epigallocatechin gallate and retinoic acid in cervical adenocarcinoma.
Yokoyama M; Noguchi M; Nakao Y; Ysunaga M; Yamasaki F; Iwasaka T
Gynecol Oncol; 2008 Feb; 108(2):326-31. PubMed ID: 18035403
[TBL] [Abstract][Full Text] [Related]
15. Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells.
Cho SD; Li G; Hu H; Jiang C; Kang KS; Lee YS; Kim SH; Lu J
Nutr Cancer; 2005; 52(2):213-24. PubMed ID: 16201852
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin gallate induced apoptosis in Sarcoma180 cells in vivo: mediated by p53 pathway and inhibition in U1B, U4-U6 UsnRNAs expression.
Manna S; Banerjee S; Mukherjee S; Das S; Panda CK
Apoptosis; 2006 Dec; 11(12):2267-76. PubMed ID: 17041754
[TBL] [Abstract][Full Text] [Related]
17. The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1.
Yuan Z; Cao K; Lin C; Li L; Liu HY; Zhao XY; Liu L; Deng HX; Li J; Nie CL; Wei YQ
Mol Med; 2011; 17(11-12):1262-74. PubMed ID: 21863213
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines.
Ayyagari VN; Diaz-Sylvester PL; Hsieh TJ; Brard L
PLoS One; 2017; 12(9):e0185111. PubMed ID: 28931042
[TBL] [Abstract][Full Text] [Related]
19. PSC 833 modulation of multidrug resistance to paclitaxel in cultured human ovarian carcinoma cells leads to apoptosis.
Duraj J; Sedlak J; Bies J; Chovancova J; Chorvath B
Anticancer Res; 2002; 22(6A):3425-8. PubMed ID: 12530099
[TBL] [Abstract][Full Text] [Related]
20. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
